BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 10023686)

  • 1. Cyclin C/CDK8 and cyclin H/CDK7/p36 are biochemically distinct CTD kinases.
    Rickert P; Corden JL; Lees E
    Oncogene; 1999 Jan; 18(4):1093-102. PubMed ID: 10023686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three RNA polymerase II carboxyl-terminal domain kinases display distinct substrate preferences.
    Ramanathan Y; Rajpara SM; Reza SM; Lees E; Shuman S; Mathews MB; Pe'ery T
    J Biol Chem; 2001 Apr; 276(14):10913-20. PubMed ID: 11278802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional activity of positive transcription elongation factor b kinase in vivo requires the C-terminal domain of RNA polymerase II.
    Napolitano G; Majello B; Licciardo P; Giordano A; Lania L
    Gene; 2000 Aug; 254(1-2):139-45. PubMed ID: 10974544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclin C/CDK8 is a novel CTD kinase associated with RNA polymerase II.
    Rickert P; Seghezzi W; Shanahan F; Cho H; Lees E
    Oncogene; 1996 Jun; 12(12):2631-40. PubMed ID: 8700522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TFIIH is negatively regulated by cdk8-containing mediator complexes.
    Akoulitchev S; Chuikov S; Reinberg D
    Nature; 2000 Sep; 407(6800):102-6. PubMed ID: 10993082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of TFIIH-associated kinase activity by complex formation and its relationship with CTD phosphorylation of RNA polymerase II.
    Watanabe Y; Fujimoto H; Watanabe T; Maekawa T; Masutani C; Hanaoka F; Ohkuma Y
    Genes Cells; 2000 May; 5(5):407-23. PubMed ID: 10886368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1 Tat-associated RNA polymerase C-terminal domain kinase, CDK2, phosphorylates CDK7 and stimulates Tat-mediated transcription.
    Nekhai S; Zhou M; Fernandez A; Lane WS; Lamb NJ; Brady J; Kumar A
    Biochem J; 2002 Jun; 364(Pt 3):649-57. PubMed ID: 12049628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three cyclin-dependent kinases preferentially phosphorylate different parts of the C-terminal domain of the large subunit of RNA polymerase II.
    Pinhero R; Liaw P; Bertens K; Yankulov K
    Eur J Biochem; 2004 Mar; 271(5):1004-14. PubMed ID: 15009212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative genomics of cyclin-dependent kinases suggest co-evolution of the RNAP II C-terminal domain and CTD-directed CDKs.
    Guo Z; Stiller JW
    BMC Genomics; 2004 Sep; 5():69. PubMed ID: 15380029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-loop phosphorylation stabilizes the CDK7-cyclin H-MAT1 complex in vivo and regulates its CTD kinase activity.
    Larochelle S; Chen J; Knights R; Pandur J; Morcillo P; Erdjument-Bromage H; Tempst P; Suter B; Fisher RP
    EMBO J; 2001 Jul; 20(14):3749-59. PubMed ID: 11447116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tat modifies the activity of CDK9 to phosphorylate serine 5 of the RNA polymerase II carboxyl-terminal domain during human immunodeficiency virus type 1 transcription.
    Zhou M; Halanski MA; Radonovich MF; Kashanchi F; Peng J; Price DH; Brady JN
    Mol Cell Biol; 2000 Jul; 20(14):5077-86. PubMed ID: 10866664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of CDK7-carboxyl-terminal domain kinase activity by the tumor suppressor p16(INK4A) contributes to cell cycle regulation.
    Nishiwaki E; Turner SL; Harju S; Miyazaki S; Kashiwagi M; Koh J; Serizawa H
    Mol Cell Biol; 2000 Oct; 20(20):7726-34. PubMed ID: 11003668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cyclin H/cdk7/Mat1 kinase activity is regulated by CK2 phosphorylation of cyclin H.
    Schneider E; Kartarius S; Schuster N; Montenarh M
    Oncogene; 2002 Aug; 21(33):5031-7. PubMed ID: 12140753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of CAK kinase activity by p53.
    Schneider E; Montenarh M; Wagner P
    Oncogene; 1998 Nov; 17(21):2733-41. PubMed ID: 9840937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 is phosphorylated by CDK7-cyclin H in a p36MAT1-dependent manner.
    Ko LJ; Shieh SY; Chen X; Jayaraman L; Tamai K; Taya Y; Prives C; Pan ZQ
    Mol Cell Biol; 1997 Dec; 17(12):7220-9. PubMed ID: 9372954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reciprocal activation by cyclin-dependent kinases 2 and 7 is directed by substrate specificity determinants outside the T loop.
    Garrett S; Barton WA; Knights R; Jin P; Morgan DO; Fisher RP
    Mol Cell Biol; 2001 Jan; 21(1):88-99. PubMed ID: 11113184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Xenopus phospho-CDK7/cyclin H expressed in baculoviral-infected insect cells.
    Lawrie AM; Tito P; Hernandez H; Brown NR; Robinson CV; Endicott JA; Noble ME; Johnson LN
    Protein Expr Purif; 2001 Nov; 23(2):252-60. PubMed ID: 11676600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cdk-activating kinase complex is a component of human transcription factor TFIIH.
    Shiekhattar R; Mermelstein F; Fisher RP; Drapkin R; Dynlacht B; Wessling HC; Morgan DO; Reinberg D
    Nature; 1995 Mar; 374(6519):283-7. PubMed ID: 7533895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The HIV transactivator TAT binds to the CDK-activating kinase and activates the phosphorylation of the carboxy-terminal domain of RNA polymerase II.
    Cujec TP; Okamoto H; Fujinaga K; Meyer J; Chamberlin H; Morgan DO; Peterlin BM
    Genes Dev; 1997 Oct; 11(20):2645-57. PubMed ID: 9334327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclin-dependent kinase inhibitor p16INK4A inhibits phosphorylation of RNA polymerase II by general transcription factor TFIIH.
    Serizawa H
    J Biol Chem; 1998 Mar; 273(10):5427-30. PubMed ID: 9488660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.